Altered phosphorylation and oligomerization of p53 in adenovirus type 12-transformed cells. 1995

W T Steegenga, and A Shvarts, and T van Laar, and A J van der Eb, and A G Jochemsen
Sylvius Laboratories, Leiden University, The Netherlands.

Loss of function of the tumor-suppressor protein p53 is, in general, either caused by mutation, inducing a conformational change, or by binding to inactivating cellular (e.g. MDM2) or viral (e.g. SV40 large T) proteins. In adenovirus type 12 (Ad12)-transformed cells, p53 is stabilized without detectable binding to the Ad12 E1B/54 kDa protein and still present in a wild-type conformation but contains a mutant-like activity in cellular transformation. In this study we examined whether the changed characteristics of p53 in Ad12-transformed cells are correlated with changes in phosphorylation or complex formation of the protein. By making tryptic phosphopeptide maps we found a significant increase in the phosphorylation of the N-terminus of p53. Furthermore, expression of E1A was found to be essential for the altered phosphorylation, while expression of only Ad12 E1B/54 kDa is sufficient to increase the protein half-life. Additionally, we observed p53 to be present in increased molecular weight complexes in Ad12-transformed cells. We conclude that both the phosphorylation and oligomerization of p53 is changed as a result of Ad12 transformation.

UI MeSH Term Description Entries
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002472 Cell Transformation, Viral An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus. Transformation, Viral Cell,Viral Cell Transformation,Cell Transformations, Viral,Transformations, Viral Cell,Viral Cell Transformations
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000256 Adenoviridae A family of non-enveloped viruses infecting mammals (MASTADENOVIRUS) and birds (AVIADENOVIRUS) or both (ATADENOVIRUS). Infections may be asymptomatic or result in a variety of diseases. Adenoviruses,Ichtadenovirus,Adenovirus,Ichtadenoviruses
D001704 Biopolymers Polymers synthesized by living organisms. They play a role in the formation of macromolecular structures and are synthesized via the covalent linkage of biological molecules, especially AMINO ACIDS; NUCLEOTIDES; and CARBOHYDRATES. Bioplastics,Bioplastic,Biopolymer
D016159 Tumor Suppressor Protein p53 Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER. p53 Tumor Suppressor Protein,Cellular Tumor Antigen p53,Oncoprotein p53,TP53 Protein,TRP53 Protein,p53 Antigen,pp53 Phosphoprotein,Phosphoprotein, pp53
D017501 Adenovirus E1B Proteins Proteins transcribed from the E1B region of ADENOVIRUSES which are involved in regulation of the levels of early and late viral gene expression. Adenovirus E1B 19K Protein,Adenovirus 12 Early Region 1B 19K Protein,Adenovirus E1B Protein,E1B Protein, Adenovirus,E1B Proteins, Adenovirus

Related Publications

W T Steegenga, and A Shvarts, and T van Laar, and A J van der Eb, and A G Jochemsen
September 1978, The Journal of general virology,
W T Steegenga, and A Shvarts, and T van Laar, and A J van der Eb, and A G Jochemsen
January 1977, Cell,
W T Steegenga, and A Shvarts, and T van Laar, and A J van der Eb, and A G Jochemsen
January 1982, International journal of cancer,
W T Steegenga, and A Shvarts, and T van Laar, and A J van der Eb, and A G Jochemsen
February 1977, Virology,
W T Steegenga, and A Shvarts, and T van Laar, and A J van der Eb, and A G Jochemsen
March 1969, The Tohoku journal of experimental medicine,
W T Steegenga, and A Shvarts, and T van Laar, and A J van der Eb, and A G Jochemsen
March 1988, Virology,
W T Steegenga, and A Shvarts, and T van Laar, and A J van der Eb, and A G Jochemsen
October 1980, Journal of virology,
W T Steegenga, and A Shvarts, and T van Laar, and A J van der Eb, and A G Jochemsen
May 1976, Virology,
W T Steegenga, and A Shvarts, and T van Laar, and A J van der Eb, and A G Jochemsen
June 1967, The Tohoku journal of experimental medicine,
W T Steegenga, and A Shvarts, and T van Laar, and A J van der Eb, and A G Jochemsen
September 1981, Journal of virology,
Copied contents to your clipboard!